Edit search
Favorable outcome in clinically stage II melanoma patients i…
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
Article, Chapter
Authors: I.S. van Houdt
Publication: Volume:123, Issue:3, Page(s):609-615
Published: 2008
Browse related articles
  Request a copy of this item
Cite this item